The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.

The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.

Bayer today announced that the U.S. Food and Drug Administration (FDA) approved AMBELVIST® (gadoquatrane), a new, intravenous macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) indicated for ...

For the first time, researchers have confirmed an association between a common magnetic resonance imaging (MRI) contrast agent and abnormalities on brain MRI, according to a new study. The new study ...

Brain MRI without contrast agent is just as effective as the contrast-enhanced approach for monitoring disease progression in patients with multiple sclerosis (MS), according to a new study in the ...

Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Global MRI Contrast Media Market - Outlook & Forecast 2024-2029" report has been added to ResearchAndMarkets.com's offering. The global MRI contrast ...

Intestinal ultrasound demonstrates strong agreement with MRI in assessing Crohn’s disease activity, supporting its use as a ...

Magnetic resonance imaging (MRI) makes internal body structures visible. However, before humans or animals are put into the "tube," they are injected with a contrast agent to make visibility possible ...

People with a history of allergic-like reactions to iodinated contrast media, which is used in a variety of X-ray-based procedures, such as CT and angiography, are susceptible to similar reactions ...

If you’ve ever had a weird pain, chronic illness, or injury that won’t quit, odds are you’ve had an MRI—and the experience can be interesting, to say the least. Being stuck inside a loud magnetic tube ...